Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > News > Volunteer enrolments commence for Vivagel™ Phase 1 Study

November 12th, 2003

Volunteer enrolments commence for Vivagel™ Phase 1 Study

Abstract:
Starpharma Pooled Development Limited is pleased to announce that volunteer enrolment has now commenced for the VivaGel™ Phase I human safety study following receipt of final ethical approval from the Royal Adelaide Hospital Ethics Committee. This trial of VivaGel™ is creating a precedent as it is the first dendrimer nano-drug to advance to clinical trials under the FDA regulatory system.

Source:
Starpharma

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

An 'EpiPen' for spinal cord injuries July 12th, 2019

Nanotechnology delivers hepatitis B vaccine: X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response. The material can give rise to a polyvaccine against six diseases July 12th, 2019

Sheaths drive powerful new artificial muscles July 11th, 2019

Nanotechnology pioneer Chad Mirkin wins Kabiller Prize in Nanoscience and Nanomedicine: Molly Stevens of Imperial College London receives Kabiller Young Investigator Award July 11th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project